Array BioPharma Selects Medidata Rave(R) as Enterprise-Wide Electronic Data Capture Solution



    Company Chooses Medidata Due to Superior Product Functionality and
Corporate Vision

    NEW YORK, December 10 /CNW/ - Medidata Solutions today announced that
Array BioPharma has chosen Medidata Rave(R) as its enterprise-wide electronic
data capture (EDC) solution. Over a period of three years, Array BioPharma
plans to conduct more than 20 studies using Medidata Rave for Phase I and II
trials in the therapeutic areas of oncology and inflammation.

    Established in 1998, Array BioPharma seeks to be the most efficient
inventor of therapeutic products in the pharmaceutical industry. The
biopharmaceutical company focuses specifically on the discovery, development
and commercialization of orally active drugs to address significant unmet
clinical needs. In 2006, Array's IT department undertook the task of putting
EDC in place as a critical component to running clinical trials. Array
BioPharma comprised a list of key EDC providers and quickly narrowed it down
to a group of five players. After examining each company's application
services provider (ASP) model, Array selected two vendors for a technical
product analysis.

    Array's scientific computing group then conducted a year-long evaluation
with input from upper management, and Medidata Solutions was selected due to
the company's superior product functionality. Specifically, Array was
impressed with the single platform design of Medidata Rave for EDC and
clinical data management, with its ability to easily pull data for a variety
of reporting needs.

    "Medidata Rave is an intuitive, easy to use solution - even for users who
were new to the system. Using Rave, clinical research associates (CRAs) can
access data and site information earlier and become better prepared for more
productive site visits. In addition, Rave's ability to build forms
electronically on our initial trials has resulted in improved protocol design
for clinical study managers," said Jim Rizzi, senior director of computational
technology at Array BioPharma. "We have been continually impressed with
Medidata's corporate culture, the vision of the company's executives and the
professionalism of its services team. We look forward to improved results by
leveraging Rave as the center of our clinical process."

    Array BioPharma plans to use Medidata service offerings to provide
training and help desk support, hosting services and integrations as well as
collaborations, integrating Rave into unique customer tools.

    "Array BioPharma is an innovative, forward-thinking company that stays at
the cutting edge of clinical trial development, and we are excited for the
improvements Medidata Rave will bring to Array's clinical process," said Tarek
Sherif, CEO of Medidata Solutions. "The company's enterprise-wide deployment
of Medidata Rave speaks to the rapid acceptance of our technology within the
mid-market and the ability of our team to successfully execute Rave
deployments for sponsors of all sizes."

    About Array BioPharma

    Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule drugs
to treat patients afflicted with cancer and inflammatory diseases. Our
proprietary drug development pipeline includes clinical candidates that are
designed to regulate therapeutically important target proteins and are aimed
at large market opportunities. In addition, leading pharmaceutical and
biotechnology companies collaborate with Array to discover and develop drug
candidates across a broad range of therapeutic areas. For more information on
Array, please go to www.arraybiopharma.com.

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.




For further information:

For further information: Lois Paul & Partners Susan Lombardo,
781-782-5767 susan_lombardo@lpp.com

Organization Profile

MEDIDATA SOLUTIONS WORLDWIDE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890